About us
Therapeutic focus
Our Platform
Clinical Programs
- NP-MP1
News & Events
Careers
- Vacancies
- Values

NP-MP1

Search

Recent Posts

NanoPhoria Bioscience secures €83.5 Million Series A to Advance Breakthrough Heart Failure Therapy and Expand Portfolio for Novel Nano-in-Micro Delivery Platform
NanoPhoria Bioscience Awarded €17.5 M From European Innovation Council’s Accelerator Program

Recent Comments

No comments to show.

Archives

October 2025
February 2025

Categories

Uncategorized

Connect with us

Learn more about our company and the science behind our revolutionary technology platform

Terms of use

Privacy Policy

Cookies

© NanoPhoria S.r.l. All rights reserved.
VAT number: 12246020965